NHC
National HealthCare Corporation Healthcare - Medical Care Facilities Investor Relations →
National HealthCare Corporation (NHC) closed at $158.81 as of 2026-03-20, trading 75.8% above its 200-week moving average of $90.35. The stock moved further from the line this week, up from 75.5% last week. The 14-week RSI sits at 60, indicating neutral momentum.
Trading volume is running at 1.7x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.00 ratio) is neutral — neither side is clearly dominating.
Over the past 1998 weeks of data, NHC has crossed below its 200-week moving average 21 times. On average, these episodes lasted 22 weeks. Historically, investors who bought NHC at the start of these episodes saw an average one-year return of +34.0%.
With a market cap of $2.5 billion, NHC is a mid-cap stock. The company generates a free cash flow yield of 4.4%. Return on equity stands at 11.9%. The stock trades at 2.3x book value.
Over the past 33.2 years, a hypothetical investment of $100 in NHC would have grown to $3351, compared to $2683 for the S&P 500. That represents an annualized return of 11.1% vs 10.4% for the index — confirming NHC as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: NHC vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After NHC Crosses Below the Line?
Across 18 historical episodes, buying NHC when it crossed below its 200-week moving average produced an average return of -1.8% after 12 months (median -3.0%), compared to +16.9% for the S&P 500 over the same periods. 41% of those episodes were profitable after one year. After 24 months, the average return was +25.3% vs +36.8% for the index.
Each line shows $100 invested at the moment NHC crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
NHC has crossed below its 200-week MA 21 times with an average 1-year return of +34.0% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Dec 1987 | Jun 1989 | 77 | 32.7% | -11.5% | +25390.8% |
| Jun 1989 | Jul 1989 | 2 | 1.9% | +24.8% | +22529.6% |
| Nov 1990 | Nov 1990 | 1 | 0.6% | +288.9% | +21053.8% |
| Oct 1991 | Oct 1991 | 1 | 4.4% | +390.2% | +18967.1% |
| Jul 1998 | Jun 2001 | 154 | 88.1% | -69.9% | +991.7% |
| Oct 2008 | Nov 2008 | 6 | 18.3% | -1.5% | +570.5% |
| Jan 2009 | Jan 2009 | 1 | 1.3% | -12.7% | +491.8% |
| Feb 2009 | Nov 2010 | 92 | 24.1% | -12.1% | +490.7% |
| Aug 2011 | Nov 2011 | 13 | 22.4% | +49.6% | +669.9% |
| Nov 2011 | Nov 2011 | 1 | 5.7% | +24.6% | +546.2% |
| Feb 2018 | Apr 2018 | 9 | 4.4% | +40.2% | +235.8% |
| Mar 2020 | Apr 2020 | 4 | 7.6% | +15.2% | +176.6% |
| Apr 2020 | Dec 2020 | 35 | 14.7% | +16.2% | +194.7% |
| Jan 2021 | Feb 2021 | 4 | 4.9% | +4.1% | +180.4% |
| Sep 2021 | Sep 2021 | 1 | 0.5% | +4.3% | +163.5% |
| Oct 2021 | Oct 2021 | 1 | 3.1% | -5.6% | +169.4% |
| Nov 2021 | Mar 2022 | 15 | 7.6% | -0.3% | +181.0% |
| Apr 2022 | Apr 2022 | 1 | 1.0% | -12.5% | +158.0% |
| May 2022 | May 2022 | 1 | 0.4% | -12.0% | +155.8% |
| Jun 2022 | Jun 2022 | 1 | 0.7% | -8.3% | +156.5% |
| Sep 2022 | Aug 2023 | 47 | 18.8% | +1.8% | +155.2% |
| Average | 22 | — | +34.0% | — |
Frequently Asked Questions
Is NHC below its 200-week moving average?
No. National HealthCare Corporation (NHC) is currently 75.8% above its 200-week moving average of $90.35. It would need to fall to $90.35 to cross below the line.
What is NHC's 200-week moving average price?
National HealthCare Corporation's 200-week moving average is $90.35 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when NHC drops below its 200-week moving average?
NHC has crossed below its 200-week moving average 21 times in our data. On average, buying at that moment produced a one-year return of +34.0%. These dips have historically been decent entry points. These episodes lasted 22 weeks on average.
Is NHC a good value right now?
Here's what our data says about NHC as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 60. Free cash flow yield is 4.4%. Return on equity is 11.9%. Price-to-book is 2.3x. This is not a buy or sell recommendation — always do your own research.
How does NHC compare to the S&P 500?
Over the past 33.2 years, $100 invested in NHC would have grown to $3351, compared to $2683 for the S&P 500. That's 11.1% annualized vs 10.4% for the index. NHC has outperformed the broader market over this period.
Does NHC pay a dividend?
Yes. National HealthCare Corporation currently pays a dividend yield of 161.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20